ATLAS VENTURE
Atlas Venture is an early-stage venture capital firm that creates and invests in biotech startup companies led by promising entrepreneurs focusing on life sciences innovation. Its seed-led venture creation strategy rigorously selects and focuses investment on the most compelling opportunities to build scalable businesses and realize value.
ATLAS VENTURE
Industry:
Biotechnology Health Care Pharmaceutical Venture Capital
Founded:
1980-01-01
Status:
Active
Contact:
857 201 2700
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Wordpress Plugins
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Adastra Pharmaceuticals
Adastra Pharmaceuticals provides responsible solutions to advance patient care in oncology.
Aisling Capital
Aisling Capital believes the next decade will be marked by a revolution in healthcare driven by new therapeutics generated by
Apple Tree Partners
Apple Tree Partners is a venture capital firm that invests in pharmaceuticals, biotech, medtech, and healthcare services.
ARCH Venture Partners
ARCH is an early-stage venture firm that focuses on life science discoveries to prevent, detect, and cure disease.
Argonaut Private Equity
Argonaut Private Equity is a diversified global private equity fund dedicated to building emerging market leaders.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Azure Biotech
Azure Biotech, Inc. is a newly formed, privately held women’s health company led by a team of seasoned pharmaceutical executives.
BARC
BARC Global Central Laboratories offers global, dedicated support of clinical trials for the life science industries.
BioDuro
BioDuro is a US-based, fully-integrated, end-to-end global life science outsourcing services company with a team of over 630 in Beijing,
Charles River Laboratories International
Charles River Laboratories International provides research models and outsourced preclinical services for the accelerated R&D of drugs.
Deerfield
Deerfield is a investment management firm.
EnBiotix
EnBiotix advances front-line labeled products for chronic, recurrent, and life-threatening pulmonary infections.
ExSight Ventures
ExSight Ventures is a firm that focuses on investing within the medical diagnostic industry.
Flagship Pioneering
Flagship Pioneering is a venture capital firm that invests in life sciences and healthcare companies.
Flower Orthopedics
Flower Orthopedics specializes in providing ready-for-surgery solutions.
FogPharma
FogPharma creates a new class of medicines that target human disease drivers currently considered undruggable.
Gamma Medica
Gamma Medica offers LumaGEM® MBI System, an FDA-cleared dual-headed digital imaging system.
Genesys Capital
Genesys Capital is focused on building companies in the high-growth sectors of healthcare and biotechnology.
Green Cross Holding Corp
GC holding company, which operates pharmaceutical, biotechnology, distribution system, life insurance, and healthcare entities.
Gurnet Point Capital
Gurnet Point Capital is a private equity firm that invests in de-risked life sciences companies
Hadean Ventures
Hadean is a life science fund manager that invests in life science companies across europe with a particular focus on the nordic region.
Health Enterprise Partners
Health Enterprise Partners is a private equity firm that provides its services for healthcare services and information technology companies.
Remita Health
Remita Health provides physician-driven care management services for physically weak and elderly people.
Healthbox
Healthbox is a an innovation consulting and fund management services firm, helping organization build and sustain innovation strategies.
Jennison Associates
Jennison Associates has earned a reputation for excellence by fulfilling client investment needs since its founding in 1969.
Levensohn Venture Partners
Levensohn Venture Partners manages both biotech and information technology portfolios with an emphasis on breakthrough technologies.
Lilly Asia Ventures
Lilly Asian Ventures is an investment firm that invests in promising life science companies.
McKesson Ventures
McKesson Ventures is a Venture Capital Firm.
M Ventures
M Ventures invests in innovative technologies and products with the potential to significantly impact Merck‘s core business areas.
Nemaura Pharma
Nemaura Pharma is a biotech company with headquarters and research facilities in the Advanced Technology Centre.
Nestlé Venture Capital Fund
Nestlé Venture Capital Fund manages the Nestle nutrition, health and wellness company.
Noxxon Pharma
Noxxon Pharma develops biostable aptamers and substances based on mirror image nucleic acids.
Ora
Ora is an ophthalmic clinical research and product development firm.
Orlando Health Ventures
Orlando Health Strategic Innovations will bring to life ideas, concepts and inventions from our team members and physicians.
Polaris Partners
Polaris Partners invests in healthcare and technology companies across all stages from founding to profitable growth.
Prelude
Prelude delivers actionable tools to manage early stage breast cancer with the DCIS test that enables personalized treatment.
Prospect Venture Partners
Prospect Venture Partners is a Palo Alto, California based venture capital firm with over $1B of capital under management.
Quantum Ventures Korea
Quantum Ventures Korea actively invests in companies within Technology and Bio/Healthcare industries.
Regenerative Bio
Regenerative Bio is the world's first anti-aging biotechnology company driven by artificial intelligence and cloud supercomputing.
Relay Ventures
Relay Ventures specializes mainly in startup, seed and early stage investments and provides support throughout the lifecycle of a startup.
Roche Venture Fund
The Roche Venture Fund is the name given to the corporate venture fund of the healthcare company Roche.
RyMed Technologies
RyMed Technologies develops intraluminal protection products for intravenous catheter care and maintenance management.
Saturn Partners
Since 1994, Saturn Partners has taken an active role in the formation and management of seed and early-stage technology companies.
IndieBio
IndieBio is the largest biotech startup accelerator, run by SOSV.
Think.Health
Think.Health invests as a boutique risk-taker in healthcare ventures.
Trio Health
Trio Health offers a CareLogic, a proprietary system to collect and share information from all stakeholders.
Tullis Health Investors
Tullis Health Investors is a private equity group that invests primarily in the healthcare sector.
V-Bio Ventures
V-Bio Ventures finds, builds and finances young, innovative companies with ambitions in the life sciences arena.
VIC Technology Venture Development
VIC Technology Venture Development develops healthcare and technology companies focusing on improving quality of life.
Current Advisors List
Current Employees Featured
Founder
Investors List
Renaissance Venture Capital
Renaissance Venture Capital investment in Venture Round - Atlas Venture
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-10 | Disc Medicine | Atlas Venture investment in Venture Round - Disc Medicine | N/A |
| 2022-05-17 | Remix Therapeutics | Atlas Venture investment in Series B - Remix Therapeutics | 70 M USD |
| 2022-04-19 | Sionna Therapeutics | Atlas Venture investment in Series B - Sionna Therapeutics | 110 M USD |
| 2022-04-14 | Be Biopharma | Atlas Venture investment in Series B - Be Biopharma | 130 M USD |
| 2022-02-10 | Arkuda Therapeutics | Atlas Venture investment in Series B - Arkuda Therapeutics | 64 M USD |
| 2022-01-05 | Korro Bio | Atlas Venture investment in Series B - Korro Bio | 116 M USD |
| 2021-12-09 | K36 Therapeutics | Atlas Venture investment in Series A - K36 Therapeutics | 30 M USD |
| 2021-12-01 | Curie Therapeutics | Atlas Venture investment in Series A - Curie Therapeutics | 75 M USD |
| 2021-11-29 | HotSpot Therapeutics | Atlas Venture investment in Series C - HotSpot Therapeutics | 100 M USD |
| 2021-10-14 | Rectify Pharmaceuticals | Atlas Venture investment in Series A - Rectify Pharmaceuticals | 100 M USD |
Newest Events participated
Participated in Liquidity Event
on 2015-02-24 as sponsor